ArticleSurgery today2026
Cystic duct management in subtotal cholecystectomy: is closure necessary?
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe Tokyo Guidelines 2018 recommend subtotal cholecystectomy (SC) as a bailout procedure for severe cholecystitis; however, closure of the cystic duct orifice (CDO) or remnant gallbladder is not always feasible. We compared the short-term outcomes of SC with and without such closures.
methodsA total of 47 patients who underwent SC at two institutions between 2012 and 2022 were included. The patients were classified into closure (CDO or remnant gallbladder closed; n = 35) and non-closure (neither closed; n = 12) groups. The primary outcome was Clavien-Dindo (CD) grade ≥ II complications. Secondary outcomes included intraoperative events, reinterventions, length of stay, and surgery-related mortality rates.
resultsThe baseline characteristics were similar. CD grade ≥ II and ≥ III complications occurred in 28.6% vs. 41.7% (p = 0.481) and 11.4% vs. 25.0% (p = 0.350) in the closure vs. non-closure groups, respectively. CD grade ≥ III bile leakage was higher in the non-closure group (5.7% vs. 25.0%, p = 0.097). No intraoperative bile duct injuries occurred. The length of stay was longer in the non-closure group (median [IQR], 27.5 [19.8-33] vs. 7 [5-14.5] days; p < 0.001), and mortality was rare.
conclusionSC without closure of the CDO or remnant gallbladder may be reserved for carefully selected patients when closure is infeasible or unsafe.
Indexed as
Identifiers
42423781What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.